Can a wearable sensor beat Finger-Prick tests for type 2 diabetes?
NCT ID NCT06587438
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This trial asks whether real-time continuous glucose monitoring (CGM) can improve blood sugar control in adults with type 2 diabetes who do not use insulin. Participants will either use a CGM device or stick to standard self-monitoring with a blood glucose meter. The study tracks changes in HbA1c, a key marker of long-term blood sugar levels, over 24 weeks. If CGM proves beneficial, it could offer a more convenient and effective way to manage diabetes without insulin.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Real-time continuous glucose monitoring (CGM) device
- What this could lead to
- If effective, this could support wider use of CGM for people with type 2 diabetes who do not take insulin, potentially improving blood sugar control and reducing complications.
- What could go wrong
- The trial is relatively small and early, and results may not apply to all patients. CGM devices can be costly and may not be accessible to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Hospital
Beijing, Beijing Municipality, China
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
-
Renmin Hospital of Wuhan University (Hubei General Hospital)
Wuhan, Hubei, 430060, China
-
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, 200233, China
-
The Eighth Affiliated Hospital of Southern Medical University
Shunde, Guangdong, China
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- FitBit coaching may help amputees walk more after surgery
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?